Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Report ID | 168502 |
Drug Identification Number | 02139383 |
Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Common or Proper name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | VANCOMYCIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 20 mL |
ATC code | J01XA |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-15 |
Estimated end date | Unknown |
Actual end date | 2023-04-01 |
Shortage status | Resolved |
Updated date | 2023-04-05 |
Company comments | This product will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-09-01 | English | Compare |
v2 | 2022-09-01 | French | Compare |
v3 | 2023-04-05 | English | Compare |
v4 | 2023-04-05 | French | Compare |
Showing 1 to 4 of 4